The possible involvement of oxidative damage in the progression of atherosclerosis has been suggested. There is some evidence that antioxidant therapy may be beneficial for the prevention of coronary heart disease. In this study, we investigated the relationship between coronary artery disease (CAD) and serum antioxidative status by measuring the total antioxidant status (TAS). Other relevant antioxidants, such as retinol, α, γ-tocopherol, ascorbic acid, α, β-carotenoids, erythrocyte glutathione peroxidase (GSH-Px) and oxidative products, were also determined in 31 male CAD patients with angiographically defined CAD and 66 male controls, aged 40-70 years, in a case-control study. The TAS levels, ratio and the concentrations of retinol, albumin, total protein and HDL cholesterol were significantly lower in the CAD patients than in the controls (p<0.01), and α-tocopherol andα/γ-tocopherol were significantly higher in the CAD patients than in the controls. The TAS level correlated positively withγ-GTP, GPT, GOT and uric acid (p<0.01). A multiple regression analysis in the CAD patients revealed that the TAS levels correlated most negatively with the number of diseased vessels. The concentrations of carotenoids and GSH-Px, as well as the α/γ-tocopherol ratio were also significantly associated. Although conditional logistic regression analysis suggested low levels of HDL-cholesterol to be a significant coronary risk factor (OR=5.1, 95% CI=1.09-24.3), the TAS level showed no significant independent contribution to CAD. This study demonstrated an association of antioxidant parameters with the atherosclerosis progression, however, it did not confirm antioxidants as an independent risk factor for CAD event. (Jpn Heart J 2001; 42: 677-690) 
to have a multifactorial etiology, composed of numerous biological, environmental, behavioral and sociocultural factors. 1) With the increasing average age of the Japanese population, it is imperative to establish the major risk factors associated with CAD and identify effective treatments and preventive strategies.
In addition to traditional risk factors, oxidative stress 2) has been regarded as one of the most important contributors to the progression of atherosclerosis. Several epidemiological studies have provided strong evidence that an increased intake of antioxidant nutrients, not only ascorbic acid, carotenoids and tocopherol, but also phenolic substances (phenolic compounds, anthocyanins, catechins and flavonoids, which are found in a wide variety of plants), may prevent oxidative stress and possibly reduce the risks of cancer, inflammation, CAD, and other conditions and diseases. [3] [4] [5] [6] Interestingly, the Zutphen Elderly study suggested the intake of dietary antioxidant flavonoids was associated with protection against CAD. 7) In addition, the "French paradox" arose from the observation that Toulouse, France, has a lower CAD mortality rate than other European areas, even though residents are exposed to coronary risk factors (dietary fat intake or high plasma cholesterol levels). One of the explanations is that red wine, which contains polyphenols, may have a protective effect against CAD. 8) In vitro experiments have suggested that red wine inhibits LDL oxidation, 9) increases antioxidant capacity in humans, 10) and reduces oxidative stress susceptibility in human plasma.
11) Extracellular antioxidants may even play a role in scavenging reactive oxygen species during reperfusion injury. 12) Several methodologies for measuring the total antioxidant capacity of biological and natural products were developed in the 1980s and 1990s. The Total Peroxyl Radical Trapping Parameter (TRAP) assay 13) and Oxygen Radical Absorbance Capacity (ORAC) assay 14) have been widely used for the measurement of antioxidant capacity in foods and biological materials. Rice-Evans, et al 15) developed the total antioxidant status (TAS) method, based on inhibition of the radical cation absorbance caused by antioxidants. The TAS method is a particularly simple and accurate method of estimating the total antioxidant capacity of plasma. Consequently, this method has been used in various clinical subjects, including premature neonates, 16) patients with diabetes mellitus, 17) and patients who have undergone a cardiopulmonary bypass. 18) Furthermore, Lantos showed that plasma antioxidant capacity as measured by the TAS method was significantly reduced in patients with CAD or hypertension, or who had undergone a cholecystectomy, as compared with healthy subjects. 19) In this study, we analyzed the total antioxidant capacity in CAD patients and healthy subjects using the TAS method. Other antioxidant components, such as retinol, ascorbic acid, α, γ-tocopherol, carotenoids (α, β-carotene) and TBARS, Vol 42 No 6 an oxidative marker, were also measured to investigate the association of TAS levels with antioxidant components and CAD.
SUBJECTS
Forty-five patients less thar than 70 years old in whom coronary angiography was performed at Juntendo Medical University from April to December in 1999 were included in the study. CAD patients were defined as having at least 75 % narrowing in at least one major coronary artery. Excluded from the study were patients undergoing arteriography for reasons other than chest pain or a positive exercise stress test. The cases consisted of 1-VD (n=9), 2-VD (n=13), and 3-VD (n=9), for a total of 31 CAD subjects, and 0-VD (n=14). Clinical details were recorded for each patient upon inclusion in the study. Nitrates, lipid-lowering agents, antithrombotic agents and antihypertensive drugs were prescribed for most of the CAD patients. Dietary advice was given to all patients. Patients with valvular heart disease, acute myocardial infarction and chronic systemic disease (inflammatory or infectious), or subjects with a history of IDDM and probucol administration to lower lipid levels, which is known to be a strong free radical scavenger, were also excluded from the study.
They were matched with respect to age (±5 years), and a case-control ratio of 1:2 was planned. The subjects were selected for the largest number of matching pairs SD 21 pairs (21 cases and 42 controls) were used for the analysis.
Of 106 healthy male adults who visited the health center as part of an occupational health check-up for small or medium sized companies consisting of less than 50 employees in Tachikawa City, Tokyo, Japan, 66 persons were able to participate in this study. Subjects with a history of CAD or DM were excluded from the control group. Verbal and written explanations of the study were given to all subjects who subsequently provided informed consent for participation in the study.
METHODS
Coronary angiography (CAG): Selective CAG was performed in fasting, nonsedated patients. The distribution of cases with coronary sclerosis, coronary spasm and miscellaneous CAD was investigated, and the relationship between the clinical diagnosis and the presence of coronary lesions was analyzed. The criteria for myocardial infarction included the sudden onset of chest pain and typical electrocardiographic findings. Angina pectoris was based on the presence of typical chest pain and subsequent CAG findings. Blood sampling: Ten milliliters of blood was obtained by vein puncture and cen-trifuged at 3,000 rpm for 10 minutes to separate the serum. Serum cholesterol, triglycerides, uric acid, creatinine, total protein, LDL cholesterol, and HDL cholesterol were determined enzymatically. GOT, GPT and γ-GTP were measured using the Japanese Society of Clinical Chemistry (JSCC) method. The body mass index (BMI) was calculated as body weight (kg)/height 2 (m). The above clinical parameters, as well as TBARS and erythrocyte GSH-Px levels, were measured within 24 hours, and the ascorbic acid levels were measured within 3 days of the blood sampling. The storage times of samples for other parameters, TAS, retinol, tocopherol and carotenoids were no more than 3 months after drawing the blood. Risk factor assessment: Details on commonly implicated risk factors and general dietary and socioeconomic information were obtained from each subject using a questionnaire. The assessed risk factors consisted of smoking habit, history of diabetes, hypertension and serum lipid levels. Smoking habit was classified as former smokers, present smokers and non-smokers, and questions were asked regarding the number of cigarettes smoked per day and for how many years. Hypertension was defined according to WHO guidelines 20) for any time in the patients' history or for a history of being treated for hypertension. Diabetes mellitus was diagnosed using a 75 g glucose tolerance test. A history of having been treated for diabetes in the past was also included in the diabetes classification. Obesity was defined as BMI >25 kg/m 2 . Low HDL-cholesterol was defined as <40 mg/dl, according to the guideline of the Japan Atherosclerosis Society.
21)

Serum antioxidants and TBARS:
Total antioxidant status (TAS). TAS was measured using a spectrophotometric method based on the antioxidant-induced inhibition of the absorbance of radical cations of 2,2-azinobis (3-ethylbenzo-thiazoline 6-sulfonate) (ABTS • ), which has a characteristic long wavelength absorption spectrum with peaks at 660, 734 and 820 nm. 15 ) ABTS +• is generated by the reaction of ABTS with the ferrylmyoglobin radical species. Antioxidant compounds suppress absorbance of the ABTS +• radical in a manner that is dependent on the antioxidant capacity. Serum TAS was found to be stable for 3 months at -30°C. Ascorbic acid. Serum ascorbic acid was analyzed using an ion-exclusive HPLC method, and post-column derivatization with 0.1 M sodium hydroxide containing 50 mM sodium borohydride. 22) A 300 µl aliquot of serum was mixed with 300 µl of 5% metaphosphic acid, and the mixture was centrifuged for 10 minutes at 12,000 rpm and 4°C. Ten microliters of the supernatant was then injected into the HPLC system. Retinol and tocopherol. The concentrations of retinol and α,γ-tocopherol in the serum were measured by HPLC. A 200 µl aliquot of serum was used to extract fat soluble vitamins using 10% ethyl acetate in n-hexane after saponification with 60% KOH (30 minutes, 70°C). PMC (2,2,5,7,8-penta-methyl-6-hydroxycouma-Vol 42 No 6 rine) was added as an internal standard. A total of 4.5 ml of 1.0% NaCl was added, and the mixture was centrifuged for 5 minutes at 2,500 rpm and 4°C. The 10% ethyl acetate in n-hexane layer was evaporated under argon at 35°C and resolved in 200 µl of n-hexane to analyze the amounts of tocopherols. A 10 µl aliquot of the final extract was injected into the HPLC system. 23) For the retinol analysis, the extract was again evaporated to dryness under argon at 35°C and resolved in 200 µl of ethanol. A 10 µl aliquot of the final extract was then injected into the HPLC system. 24) Carotenoids (α, β-carotene). A 500 µl aliquot of serum was used to extract the carotenoids using n-hexane. A total of 4.5 ml of 1.0% NaCl was added, and the mixture was centrifuged for 5 minutes at 2,500 rpm and 4°C. The n-hexane layer was evaporated to dryness under argon at 35°C and resolved in 200 µl of HPLC solvent for the carotenoid analysis. A 10 µl aliquot of the final extract was then injected into the HPLC system. 25) Results are given for retinol and tocopherol levels and their ratios to the cholesterol level because the matched results alone were insufficient to remove the strong correlation between cholesterol and tocopherol in the data. Antioxidant Enzyme. Erythrocytes were hemolyzed by addition of redistilled water and vigorous vortexing. Erythrocyte glutathione peroxidase (GSH-Px) activity was estimated in hemolysates by using a coupled enzyme procedure, based on the following principle: GSH-Px catalyzes the oxidation of glutathione by H 2 O 2 . In the presence of glutathione reductase and NADPH, the oxidized glutathione is immediately converted to the reduced form with a concomitant oxidation of NADPH to NADPH + . The decrease in absorbance at 340 nm was measured. 26) One unit of enzyme is calculated as 1 nmole of NADPH per one milliliter of serum for 1 minute. TBARS. The TBARS concentration was measured by the Mihara method. 27) Absorbance was measured spectrophotometrically at 550 nm using a Shimadzu spectrophotometer. Statistical analysis : We compared the means of continuous variables between CAD cases and controls using a paired t-test, while the χ 2 -test was used to compare discontinuous variables. Associations between the TAS score and other clinical parameters were estimated using Pearson's correlation coefficients. To investigate the association between the number of diseased vessels and other clinical parameters, including age, lipid profile (TCHO, LDL-C, HDL-C, TG), antioxidants (albumin, UA, retinol, α/γ-tocopherol ratio, ascorbic acid, TAS, GSHPx), and TBARS in this model, a backward elimination multiple linear regression analysis was used. The final model included only the following variables that were associated with CAD at a significance level of p<0.10: TAS, α/γ-tocopherol ratio, carotenoids, GSH-Px and TBARS.
We used odds ratios to estimate the relative risks. To compare the relative importance of each variable among our study subjects, we calculated the standardized odds ratios (OR) and 95% confidence intervals (CI) using the estimated standard unit of change for each predictor variable. The association between the independent variables and CAD event was estimated, including BMI, hypertension, low HDL cholesterol, and TAS by conditional logistic regression analysis.
Because the TAS distribution was skewed, the natural logarithms of the variables were used in all calculations. A p value of less than 0.05 was considered statistically significant, unless otherwise specified. All statistical analyses were performed using HALBAU software (HALBAU-4, Gendai Sugakusha).
RESULTS
Demographic and biochemical characteristics:
The demographic and biochemical characteristics of the study groups are shown in Table I . Compared with the control subjects, the CAD patients had lower levels of HDL cholesterol and total protein, and higher levels of TG and BMI. However, other traditional risk factors did not differ between the two groups. The controls had a higher diastolic blood pressure, however, there was no difference in systolic blood pressure. This finding may be explained by the fact that 40% of the CAD patients were taking anti- hypertensive medication. With respect to smoking and drinking habits, 70-80% of the CAD patients had stopped smoking and drinking, suggesting that they had adopted life-style modifications. Serum antioxidant levels: No significant differences in serum TBARS or antioxidant levels were found between CAD patients and one-to-two age-matched control subjects (21 pairs), except for the several parameters shown in Table II . Levels of TAS, retinol, TBARS and albumin were significantly lower and α-tocopherol levels were significantly higher in the CAD patients than in the control subjects. The α/γ-tocopherol ratio of the CAD patients was significantly higher than that of the control subjects.
Association between TAS and classical coronary risk factors and serum antioxidants:
The concentrations of TP, γ-GTP, GPT, GOT, and uric acid positively correlated with the TAS level in all subjects (n=111) ( Table III) .
Association between the number of diseased vessels and serum antioxidants and classical coronary risk factors: Independent risk factors for progressive CAD were examined using a multiple linear regression analysis in CAD (1-3 DV) (n=31) (Table IV) . Consequently, the number of diseased vessels was found to be negatively associated with the TAS level, the concentrations of carotenoids and GSH-Px, and the α/γ-tocopherol ratio. The dose-response relationship between the number of diseased vessels and TAS levels was also examined in 45 cases (0-3 diseased vessels). TAS levels tended to decrease with the number of vessel disease (VD), which were 220 mM in 0-VD, 208 mM in 1-VD, 192 mM in 2-VD, and 109 mM in 3-VD (p=0.95). (n=42) log TAS1000 (mM) Uric acid mg/dl (mmol/l) α-tocopherol µg/ml (µmol/l) α-tocopherol/cholesterol ratio α/γ tocopherol ratio Ascorbic acid µg/ml (µmol/l) Retinol µg/ml (µmol/l) β-carotene µg/ml (µmol/l) α, β-carotene µg/ml (µmol/l) Albumin (g/dl) ery GSH-Px (U/gHb) 
Influence of antioxidants on CAD:
The magnitude of the association between CAD and the independent CAD risk factors BMI, hypertension, HDL-cholesterol and TAS was estimated using conditional logistic regression analysis in CAD patients (n=21) and one-to-two controls (n=42) ( Table V) 
DISCUSSION
This study aimed to examine the antioxidant hypothesis and the possible role of antioxidant capacity in the prevention of cardiovascular disease, on the assumption that the oxidation of LDL cholesterol in vessel walls is one of the steps involved in atherogenesis. Our data revealed serum TAS levels in CAD patients to be significantly lower than those of control subjects. Furthermore, Uric acid (mg/dl) α-tocopherol (µg/ml) Ascorbic acid (µg/ml) Retinol (µg/ml) β-carotene (µg/ml) α-carotene (µg/ml) antioxidant levels, including TAS, α,β-carotene and GSH-Px, were found to be negatively associated with angiographic CAD severity.
Some clinical studies using the TAS method to investigate the association of antioxidant capacity with CAD have been previously reported. Semra, et al observed no difference in TAS levels between CAD patients and control subjects. 28) Markovics, et al reported that TAS levels in patients with acute myocardial infarction did not change, 29) whereas Fazenda, et al reported that TAS levels decreased in young survivors of acute myocardial infarction. 30) In our study, TAS levels in CAD patients were significantly lower than those in the control subjects Age, lipid profile (TCHO, LDL-C, HDL-C, TG), antioxidants (albumin, UA, retinol, tocopherol ratio, ascorbic acid, TAS, GSH-Px), and TBARS are included in this model. GSH-Px=glutathione peroxidase; HDLC=high density ipoprotein cholesterol; LDL-C=low density lipoprotein cholesterol; TG=triglycerides; TAS=total antioxidant status; TBARS= thiobarbituric acid-reactive substances. 31) reported total homocysteine to be inversely correlated with total antioxidant capacity, whereas total cysteine was positively associated with total antioxidant capacity. Also, interestingly Kadota, et al found that mercaptalbumin and total SH contents were reduced in proportion to the severity of CAD. 32) Usal, et al suggested that depressed GSH levels might be associated with an enhanced protective mechanism to oxidative stress in acute myocardial infarction (AMI). 33) Even though no data regarding homocysteine metabolism disturbance, total SH content or GSH levels were obtained in our study, we strongly suspect that CAD patients might be affected by disturbance of the extracellular aminothiol redox state, leading to the development of vascular damage. Furthermore, Yegin, et al revealed that there was a decrease in both the activity of GSH-Px and Se levels in erythrocytes parallel to the increase in the severity of CAD, 34) which is consistent with our results. Erythrocyte antioxidant systems also might affect the development of atherosclerosis.
Vucic, et al suggested the possiblity that the TAS method is insufficiently sensitive to vitamins from dietary antioxidants, such as α-tocopherol, β-carotene and ascorbic acid, and is mainly affected by background antioxidants, such as uric acid, glutathione and thiols in proteins and secondary metabolites in the setting of diabetes mellitus. 17) Nagyova, et al demonstrated that vegetarians have significantly higher plasma TAS levels, although there was no correlation between β-carotene and TAS levels. 35) In addition, Saionji, et al reported TAS was significantly correlated with total proteins and uric acid, but not with vitamin C concentrations in hemodialysis patients, who are considered to have a disturbance in the homeosasis of their antioxidant status. 36) These results are consistent with ours, which show that the TAS level does not correlate with nutritional antioxidants.
α-Tocopherol is considered to be an effective antioxidant which plays a protective role against CAD. α-Tocopherol levels in patients were higher than those in the controls, which is against the antioxidant hypothesis. One explanation for these conflicting results is that the CAD patients in our study were already being managed with medication and lifestyle modifications. The CAD patients tended to intentionally eat healthy food and take vitamin supplements. In particular, the prevalence of current smoking differed significantly between the two groups. Ninety percent of the CAD patients had ceased smoking, while 60% of the controls were current smokers according to the questionnaire. Also, the oxidation status assayed by TBARS in our CAD patients might be affected by the above factors and lead to unexpected results. In general, lipid peroxidation has been Vol 42 No 6 reported to inhibit prostacyclin (PGI 2 ) in the endothelium, which in turn leads to an increase in platelet aggregation and lipid peroxides reduce the antithrombin activity and contribute to acceleration of the blood clotting process.
The plasma levels of ascorbic acid and tocopherol in the controls may have been lowered as a result of smoking, influencing the difference in TAS levels between the two groups. Several case-control studies have also reported negative results. 37, 38) Hense, et al reported that tocopherol levels high enough to offer near maximal antioxidant protection were not associated with MI. 39) Compared with average serum α-tocopherol levels, reported to be 9.24-13.96 µg/ml for Japanese males, 40) the CAD patients in our study had relatively high levels of α-tocopherol. Furthermore, Handelman, et al suggested that the α/γ-tocopherol ratio is a satisfactory index for monitoring compliance with α-tocopherol supplementation. 41) In our study, the α/γ-tocopherol ratios differed significantly between the two groups, and the α/γ-tocopherol ratio was associated with the severity of CAD. CAD patients may benefit from continuously taking tocopherol supplements after their diagnosis of CAD. Interestingly, Öhrvall, et al 42) reported that lower γ-tocopherol levels and a high α/γ-tocopherol ratio in the CAD group might reflect differences in antioxidative status as compared with healthy subjects. Although α-tocopherol is preferentially secreted in VLDL through α-tocopherol-binding protein in the liver, γ-tocopherol would be excreted in the bile. As a coronary risk factor, hypertriglyceridemia resulting from an increase in VLDL production may induce an increase in bile production, possibly leading to an increased loss of γ-tocopherol in CAD patients. [43] [44] The results of our study on coronary risk factors showed CAD patients to have relatively low HDL cholesterol levels, which is consistent with the results of other epidemiological studies. [45] [46] This finding may support the hypothesis that HDL cholesterol can preserve endothelial function by inhibiting the oxidative modification of LDL cholesterol and ameliorating the cytotoxic effects of oxidized LDL cholesterol on endothelial cells. Conclusion: Our findings indicate that a low HDL cholesterol level is the single greatest risk factor for CAD, and antioxidant capacity as measured by the TAS method is also associated with CAD. Furthermore, the levels of antioxidants, including TAS, carotenoids and GSH-Px, were significantly associated with CAD severity and the TAS level was significantly lower in CAD patients than in controls, suggesting that serum antioxidant capacity may have a protective effect against oxidative stresses. Further studies are needed to clarify the antioxidant hypothesis in relation to arteriosclerosis and to establish its clinical significance.
